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For elderly persons, the fastest-growing segment of the population, poor physical function and cognitive dysfunction are critical issues; functional impairments can cause a cascade of sequelae such as falls, loss of independence, need for hospital care, and even premature cardiovascular-as well as noncardiovascular-related death. [1] [2] [3] [4] [5] [6] Accordingly, the earliest possible action to prevent physical and cognitive dysfunction in the elderly has become a major public health challenge.
Associations between poor physical function and/or cognitive dysfunction and increased risks of cardiovascular diseases (CVDs) and all-cause mortality have been well documented, and these associations are independent of well-known cardiovascular risk factors such as high blood pressure (BP), diabetes, or dyslipidemia; 2-5 thus, it is possible that poor physical function and cognitive dysfunction could be independent markers for identifying vulnerable or frail subjects.
Hypertension is common among elderly persons and contributes substantially to poor physical function and cognitive dysfunction, to cardiovascular morbidity and mortality, and to all-cause mortality. [7] [8] [9] [10] [11] [12] Among subtypes of BP measurement, nocturnal BP level has been shown to have the greatest prognostic accuracy. [9] [10] [11] This is particularly the case in patients treated with antihypertensive drugs, as high nocturnal BP levels, or less marked nocturnal BP dipping relative to daytime BP, have been shown to predict all-cause as well as cardiovascular mortality; in contrast, daytime BP level has not been associated with these outcomes. 9 Previous results have indicated that a high nocturnal BP level in hypertensive patients is not only a direct contributor to the cardiovascular burden, but is also a marker of vulnerability or frailty in individuals with concurrent systematic abnormalities. Accordingly, we hypothesized original contributions
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that hypertensive patients with poor physical function and/ or cognitive dysfunction would have high nocturnal BP levels, as such functional problems reflect a lack of integration of the locomotor, autonomic nervous, and cardiovascular systems, 13 ,14 all of which have been shown to be involved in nocturnal BP regulation. [15] [16] [17] [18] [19] This study was conducted because there have been no reports in the literature to date that have systematically investigated this hypothesis.
Thus, we examined the association between physical function (walking speed and timed up-and-go (TUG) tests), 19 cognitive function (mini-mental state examination (MMSE)), 20 and nocturnal BP level among treated elderly hypertensive patients.
Methods
Patients. From December 2007 to May 2008, 148 consecutive patients with essential hypertension who were ≥60 years old and who had been treated at our outpatient clinic (Kitaura National Health Insurance Hospital, Miyazaki, Japan) were prospectively recruited for this study. The enrolled patients were ambulatory, lived independently, and were not nursing home residents. The exclusion criteria were as follows: people with neurodegenerative diseases including Parkinson's diseases and Huntington's disease; a history of CVDs (coronary arterial disease and cerebrovascular disease) or heart failure in the past 6 months; presence of inflammatory diseases (acute infection, autoimmune diseases); presence of malignant disease; atrial fibrillation; and absence of or incomplete sampling data. All patients completed a health questionnaire and provided their complete medical history (smoking and drinking status, use of medications, and past medical history), and underwent measurement of office and 24-h ambulatory BP monitoring, blood sampling, and physical and cognitive function tests. Daily drinking was defined as the habitual daily intake of alcohol equivalent to one "go" (a Japanese traditional unit of volume corresponding to 23 g of ethanol) or more. This study was approved by the institutional review board at Jichi Medical University, and written informed consent was obtained from all participants.
BP assessment. Office BP was measured by a digital oscillometric BP monitoring device (HEM-5041; Omron Healthcare, Kyoto, Japan) while the subjects remained seated for 5 min, and values were calculated as the mean of three consecutive measures. Within 2 weeks after the measurement of office BP, 24-h ambulatory BP monitoring was performed with an automatic oscillometric device (TM-2425; A&D, Tokyo, Japan) at 30-min intervals. 21 All subjects used their prescribed antihypertensive medications as usual during the ambulatory BP monitoring, and filled out a questionnaire about their waking time and bedtime, the perceived quality of their sleep (e.g., whether or not the recording caused a significant disruption of normal sleep), and the frequency of nocturia and nocturnal awaking during overnight BP monitoring. We defined daytime and night-time BP as the average of values from each of these two periods. We subclassified the patients according to the percentage of nocturnal systolic BP (SBP) decline (100 × (1 − night-time SBP/daytime SBP)) as follows: dipping state, if the fall in BP was ≥10%; nondipping state if the fall in BP was <10%. 21 Because diastolic BP in older persons reportedly has less impact on cardiovascular risk than SBP, we analyzed the association of cognitive or physical function with SBP, but not with diastolic BP, in this study.
Laboratory testing. Peripheral venous blood was obtained via a 21-gauge needle, with the patient in the fasting state, between 0800 and 0830 hours. Plasma was obtained by centrifuging the whole blood at 1,500g for 15 min at 4 °C, and samples were immediately frozen and stored at −40 °C until used for analysis. The concentration of insulin (Lumipulse Presto II; FujiRevio, Tokyo, Japan) was measured by SRL (Tokyo, Japan). Type 2 diabetes was defined by the use of antihyperglycemic drugs or a fasting glucose of ≥126 mg/dl. The intra-and interassay variation coefficients of each test were both <7%. To estimate renal function, the glomerular filtration rate was estimated by the Modification of Diet in Renal Disease (MDRD) study equation modified for Japanese: 194 Cr −1.094 × age −0.287 × 0.739 (for women). 22 Assessment of physical function and activity. A trained physician (T.I.) who was unaware of the patient's laboratory and ambulatory BP data evaluated walking speed and timed TUG for all participants. Walking speed, which was assessed at baseline by measuring the time in seconds that it took to complete a 10-m walk performed with maximum effort, was calculated as m/s. 5 In the TUG test, we calculated the time (timed TUG) required for the study patients to stand up from a standard chair (approximate seat height of 46 cm), walk a distance of 3 m, turn, walk back to the chair, and sit down again. Participants used their customary walking aids (e.g., cane) if necessary, but were given no assistance by the examiners. Each physical function test was performed twice, and the best time was used for the analysis. Daily physical activity was calculated as the total amount of time spent (min) per week engaged in a nonpassive activity (e.g., walking, jogging, biking).
Assessment of cognitive function.
Cognitive function was assessed using the MMSE score. The methods used for this examination have been described in detail elsewhere. 20 The MMSE values range from 0 to 30. Although there is no single consensual definition of cognitive dysfunction, most studies have classified subjects with a score ≤23 as having poor cognitive function. 20, 23 However, in this study, only 10 patients (7%) had an MMSE score ≤23, so we defined cognitive dysfunction (n = 53, mean 24.3 points) as having an MMSE score below the geometric mean (26.8) . Depressive symptoms were also evaluated, using the Geriatric Depression Scale. 24 The Geriatric Depression Scale is one of the most commonly used tools in screening older adults for depression, and past studies support its reliability and validity for evaluating depressive symptoms in varying cohorts of older adults. 24 Carotid ultrasonography. The methods used in this examination have been described in detail elsewhere. 25 Briefly, the carotid arteries were examined bilaterally at the level of the common-carotid artery, the bulb, and the internal-carotid artery, as measured from both transverse and longitudinal orientations. The region with the thickest intima-media thickness (IMT) was measured and was included in our analysis, and the value was calculated as the mean of the single thickest point in the far wall on both sides of the structure. Focal plaques, when present, were included. In repeatability analysis, the mean difference for repeat measurements of internal-carotid artery-IMT was 0.02 ± 0.15 mm (coefficient of variation: 9.54%; coefficient of correlation: r = 0.959; P < 0.001). The mean difference for repeat measurements of common-carotid artery-IMT was −0.04 ± 0.09 mm (coefficient of variation: 6.62%; coefficient of correlation: r = 0.977; P < 0.001).
Statistical analysis. All statistical analyses were performed using SPSS, version 16.0J software (SPSS, Chicago, IL). Data with normal distribution are expressed as the means ± s.d., and variables with skewed distribution were logarithmically transformed before analysis, and expressed as geometric means (interquartile range). The associations between the individual variables were calculated using Spearman's correlation method. To assess the independent association between the degree of nocturnal SBP dipping and nocturnal SBP levels, we used a multiple linear regression analysis in which a P value ≤0.05 in each Spearman's correlation coefficient was the criterion for entry into the model. Finally, our population was subdivided into four groups according to walking speed and MMSE values being above or below the geometric means (walking speed: 1.5 m/s; MMSE score: 26.8 points). Differences regarding the degree of nocturnal SBP dipping and night-time SBP level among four groups were assessed using analysis of variance and analysis of covariance by controlling for significant covariates (age, sex, plasma glucose, and high-density lipoprotein cholesterol level). Statistical significance was defined as P < 0.05.
results association of nocturnal BP level with physical and cognitive function
The patient characteristics in this study are shown in Table 1 . Table 2 shows the association between nocturnal SBP level and the degree of nocturnal SBP dipping and various clinical parameters. Both walking speed and MMSE score were found to be independently associated with nocturnal SBP level (model 1 in Table 3 ); whereas, the walking speed was significantly associated with the degree of nocturnal SBP dipping (model 1 in Table 4 ), and the association was independent of the 24-h BP levels (model 2 in Table 4 ). Among those with well-controlled 24-h BP levels (<130/80 mm Hg, n = 56), there remained significant associations between MMSE score and nocturnal SBP level (P < 0.004). Additional adjustment for the presence of CVDs in Tables 3 and 4 did not change our results (data not shown).
When we used the TUG test result instead of walking speed as a measure of physical function, we found that the timed TUG showed a tendency, though not with statistical significance, toward an association with nocturnal SBP level (model 2 in Table 3 ). Neither use of any type of antihypertensive drugs nor the morning and evening administration of antihypertensive drugs (n = 16) influenced our results (data not shown). There was a strongly inverse association between walking speed and the timed TUG test result (r = −0.743, P < 0.001).
Walking speed was significantly associated with the MMSE score (r = 0.232, P = 0.005), and this association was independent of age, sex, body mass index, the presence of a previous history of CVDs, and internal-carotid artery-IMT level original contributions
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(P = 0.002). The MMSE score was significantly associated with age, previous or present smoking habit, and 24-h SBP (all P < 0.01). When these variables that were associated with physical and cognitive function (i.e., sex, smoking status, a history of CVDs) were entered into models 1 and 2 in Tables 3 and 4 , our results remained unchanged (data not shown).
association of both lower physical and cognitive function with nocturnal BP level
As shown in Figure 1 , our subjects were divided into four groups with respect to the geometric mean level of walking speed (1.5 m/s) and MMSE score (26.8 points). The nocturnal SBP level was significantly higher in patients with both poor physical function and cognitive dysfunction than in those with either poor physical function or cognitive dysfunction alone, or in those who performed well on both tests (135 ± 20 mm Hg vs. 123 ± 24 mm Hg vs. 131 ± 19 mm Hg vs. 118 ± 15 mm Hg; P = 0.001 for linear trend). Moreover, nocturnal SBP dipping was significantly less pronounced in patients with both poor physical function and cognitive dysfunction than it was in the other groups (−6.8 ± 11.0% vs. −12.7 ± 11.5% vs. −10.0 ± 10.3% vs. −15.3 ± 8.6%; P = 0.002 for linear trend). Office and daytime BP levels were almost identical among four groups (data not shown). Because there were significant differences in age, sex, plasma glucose, and high-density lipoprotein levels among the four groups, we adjusted for these significant covariates, and the results are shown in Figure 1 , which shows that the significant associations remained unchanged (P = 0.008 for linear trend in Figure 1a and P = 0.02 for linear trend in Figure 1b) .
discussion
In this cross-sectional study of ambulatory, independently living elderly persons treated for hypertension, we demonstrated, first, that poor physical function and/or cognitive dysfunction, as assessed by slower walking speed and lower MMSE score, respectively, were individually associated with high nocturnal SBP level, independent of age, sex, body mass index, office SBP, and pulse rate, and the extent of vascular remodeling (i.e., carotid IMT). Because a high nocturnal SBP level under antihypertensive treatment is the most potent predictor of cardiovascular outcome, 9 our findings have important clinical implications, i.e., that treated elderly hypertensives who experience poor physical function and/ or cognitive dysfunction might be in a state of high cardiovascular risk requiring 24-h BP control, especially nocturnal SBP control. 
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Physical function tests require our patients to both perform and integrate basic daily movements (e.g., standing, walking); thus, the challenge requires musculoskeletal and cerebral integration. 12, 13 Accordingly, our patients with poor physical function test results may have suffered from hampered mobility during their daily activities, which could influence the daytime BP profile and in turn the reduction in nocturnal BP was not as great as that in daytime BP (i.e., less nocturnal BP dipping) in this study. In fact, we recently demonstrated that less daytime physical activity (as assessed by actigraphy) and orthostatic SBP reduction (>20 mm Hg, evaluated by a head-up tilting test) were significantly associated with diminished nocturnal BP dipping. 17, 18 In this study, we did not carry out an actigraphy series, nor did we evaluate patients for orthostatic BP changes during ambulatory BP monitoring. However, no associations between physical function and the degree of daytime SBP, pulse rate, or BP variability were found in this study; therefore, it seems unlikely that physical function alone could influence the daytime BP profile and in turn the extent of nocturnal BP dipping.
Both poor physical function and cognitive dysfunction have been associated with subclinical cerebrovascular abnormalities such as white-matter lesions and subcortical or basal ganglia lacunar infarction, [26] [27] [28] [29] which could account for the altered diurnal BP variation in these patients. 15, 16 White-matter lesions and infarction of the basal ganglia, both of which affect periventricular ascending thalamocortical and descending corticospinal fibers, interfere with long-loop reflexes that are critical for gait and balance mediated by deep white matter sensory and motor tracts; therefore, such brain abnormalities cause poor physical functioning. [27] [28] [29] In contrast, the cerebral circuitry (e.g., frontal-subcortical and cerebro-cerebral circuits) plays an important role in the maintenance of cognitive function; 30, 31 therefore, poor cognitive function has been associated with diffuse and multiple brain infarctions. 32, 33 In this study, however, we did not perform brain neuroimaging, so that we cannot refer to this possibility.
Our findings that there were significant associations between either poor physical function or cognitive dysfunction and high nocturnal SBP might only reflect a lack of integration of the multiphysiological systems in the human body (i.e., vulnerability or frailty), [13] [14] [15] [16] [17] [18] [19] as we hypothesized. In regard to this point, because of the cross-sectional nature of this study, we can infer no causal relationship between poor physical function and/or cognitive dysfunction and a high nocturnal SBP level; however, it seems plausible that high nocturnal SBP levels in treated subjects might lead to both poor physical function and cognitive dysfunction. [7] [8] 11 High nocturnal SBP levels in treated subjects might simply be caused by poor control of the 24-h BP levels. In this study, however, the association between lower cognitive function and high nocturnal SBP level remained significant even among the patients with well-controlled 24-h BP levels (<130/80 mm Hg), and the association between lower physical function and diminished nocturnal SBP dipping remained significant even after adjustment for 24-h SBP level (model 2 in Table 4 ). In the future, interventional studies are required to examine whether or not night-time SBP reduction can improve physical and cognitive functioning in elderly hypertensive persons.
This study has several limitations. First, our sample size was small, and thus, further studies with a larger sample size are needed. In particular, there was an insufficient number of subjects below a more generally accepted MMSE <23 (refs. 20, 23 ) in this study, and thus our designation of poor cognitive function as MMSE <27 points may be inappropriate. Second, we performed 24-h BP monitoring only once. Therefore, there was a lack of the reproducibility of nocturnal BP level, although the available evidence showing the clinical value of nocturnal BP level has been based entirely on a single recording of 24-h ambulatory monitoring. [9] [10] [11] Third, we did not perform sleep studies in this investigation. This may have been an important omission, as sleep apnea has been associated with nocturnal BP elevation, 34 although another study has shown that the association was attenuated among elderly persons (≥60 years). 35 Lastly, medication use was potentially confounding, because certain drugs such as angiotensin-converting enzyme inhibitors, can halt or slow declines in muscle strength and walking speed. 36 In this study, no association was observed between treatment with any particular antihypertensive drug, timing of administration of antihypertensive drug, physical function, and nocturnal BP dipping.
In conclusion, poor physical function in patients taking antihypertensive medications, particularly in those with concomitant cognitive dysfunction, could be a marker of high nocturnal SBP level; in such patients, 24-h BP control, including nocturnal BP monitoring, should be required. Further prospective studies will be needed to assess whether such targeted risk management improves the prognosis of elderly persons with hypertension.
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